Philip Morris
Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
Fields
- Author
- Lee, P.N.
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Site
- R529
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- BIBL, BIBLIOGRAPHY
- Named Organization
- Library of Congress
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Characteristic
- EXTR, EXTRA
- MISS, MISSING PAGES
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- wic02a00
Document Images
I
r
:
I
,
r
P.N. Lee
Environmental
Tobacco SmOke
and Mortall"ty
A Detailed' Review of Epidemioiogicat Evidence Relating Environmental
Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Guses
of Death in Adults Who Have Never Smoked
101 tables, 1992
K/~\RGER
Easel Munehen Paris l ondon NeW York Nrr Delhi Banskok Sinpporo -Tokyo
Sydne)
2023512110
®

Library of Congress Cataloging-inPubhcation Data
Lec. Pcter N., 1943-
Environmental tobacw smoke and morulny; a detailed reviovu or epidemiological evidence
rolating environmental tobacco smoke to the nsk of cancer, heart disease- and other wuses of'
death in ad'ults who have nevcr smoked'J P.N. Let.
Includes bibliograpfiicnl references and index
1I Passive smoking - Health upects., 2. Tobacaosmoke pollution - Health aspects.
3. Environmentally induced diseases-Tozioology. L Tttle.
(DNLM: 1. Cause of Dcath, 2~: Hean Diseases - epidcmiolog. 3. Heart Diseases -
mortality, f. Neoplasms-epidemiolbgy. S. Neoplasms-mortahq. 6. TobaccoSmoke
Pollution -adverx effects: w'A 754 U7g5eji
RA12t2 T6L4, 1992 615.9'52379 -dc20
ISBN 3-d055-5529-6
All rights rsserved..
No pan of this publiation may be tnnslated into othenlanguaaesr reproduced or utilized in
any form or by any means, eknronic or mechanicaL incJudrng photowpyirrt. eeoording,
miesocopying. or by any information storage and retrieval system, without permission ie
writing from the pubhshcr,
O Copyright 1992 by S. Karger AG. P.O. Bo:.,CH-s009 Base1 (Switzerland)
Printed in Switzerland on acid-free paper, by Thur AG OfRctdrudc, Praaela
ISBN 3-4055-5529-1>

I
I
I
h
I
i
Contents
lndez to Tables ....................................... X
.
Preface ........................................... XV
Acknowledgemenu ..................................... XX
1 I ntroduction
1.1 Background and Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I
1.2 Terms of Reference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.3 Structure of This Book . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.4 Problems of Inference from Epidemiological Studies . . . . . . . . . . . . . . . . . 4
1.5 Dosimetri.c Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.6 Misclassification of Active Smoking Status . . . . . . . . . . . . . . . . . . . . . . . 7
2 The 53 Studies
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . 9
2.2 Prospective Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . . . . . . . 9
2?:1 Amerinn Cancer Society Million Person Study - Garfinkel I . . . . . . ., . . . . . 9
2.2.2 !!apanese Study - Hirayama . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11.
2:2:3 Wcst ofScotland Study - Hole . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . l5
2.2.4 Alameda County Study - Reynolds . . . . . . . . . . . . . . . . . . . . . . . . . . . 1!8
2.2.5 Rancho Bernardo Study - Garland . . . . . . . . . . ., . . . . . . . . . . . . . . . . 19 '
2.2.6 Multipte Risk Factor, Intervention Trial - Svendsen ., . . . . . . . . . . . . . . . . 20
2.2.7 Washington County Study - Sandier 11 . ., ., . . . . . . . . ., . . . . . . . . . . . . . 22'
2.2.8 Amsterdam Study- Vandenbroucke . ., . . ., ., ., . ., . . . ., ., . . . . ., . ., . . . . . 25
2.2.9 Georgia Study - Humble II . ., . . . . . . . . . . ., . . . . . . . . . . . . . . . . . .
25
2.2.10 Californian Seventh-Day Adventists Study - Butler . . . . . . . . . . . . . . . . . . 26
2.3 Gse-Control Studies of Mor¢ than One Disease . . . . . . . . . . . . . . . . . . . ., 27
2.3.1 United' Kingdom Study - Lee . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . 27
2.3.2 North Carolina Study - Sandler I . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.3.3 Erie County Study of Cancer of All Sites - Miller . . . . . . . . . . . . . . . . . . . 32
2:4 Case-Control Studies of Lung Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2:A:1 Japanese Atomic Bomb Survivors Study- Akiba . . . . . . . . . . . . . . . . . . . 34
2:4.2 Southern Swedish Study - Axelson . . . . . . . . . . . . . . . . . . . . . . . . . . 35

2.4.3 Colondo Studv of Adenocarcinoma - Brownson . . . . . . . . . . . . . . . . . . . 36
2.4.4 Texas Study - Buffier . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.4.5 First Hong Kong Study - Chan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.4.6 Louisiana Study - Corrca . . . . . . . . . . . . . ., . . . ., . . . . . . . . . . . . . . . U
2.4.7 Shanghai Study- Gao . . . . . ., . ., . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.4.8 New JeneylOhio Study - Garfinkel II . . . . . . . . . . . . . . . . . . . . . . . . . . 40
2.4.9 Tianjin Study - Geng . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
2.4.10 New Mexico Study - Humble I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
2.4.11 Kanagawa Study - I'noue . . . . . . . . . . ... . . . . . . . . . . . . . . . . . . . . . 45
2.4.12 First New York Study - Kabat I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
2.4.13, Third New York Studv - Kabat Il l . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
2.4.14 Socond Athens Study - Kalandidi IJ . . .. . . . . . . . . .. . . . . . . . . . . . . . . 49
2:4.1!5 Nara Study - Katada . . . . . . . . .. .. . . . . . . . . . . . . . . . . . . . . . . .
. . S I'
2:4'.16 German Studv - Knoth ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . 52
2.4:17 Second Hong Kong Study - Koo . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 53
2.4.18 Third Hong Kong Study - Lam 1 . . . . . . . . . . . . . . . . . . . . . . . . . . .. .. 55
2.4.19 Fourth Hong Kong Study - Lam 11 . . . . . . . . . . . . . . . . . . . . . .. . . . . . 56
2.4.20 Shanghai Study, - Li . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . 57
2.4.21 Armadale Study - Uoyd . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
2.4.22 Swedish Study - Pershagen . . . . . . . . . . .. . .. .. . . .. . .. . . . . . . . . . . .
. . 58
2.4.23 Nagoya Study - Shimizu . ., . . ., . ., . . ., ., ., . . . . . . ., . . . . . . . . . - . .
. . 59
2:4.24 Osaka Study - Sobue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
2.4.25 Stockholm Study - Svensson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
2.4.26 Athens Study - Triehopoulos . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 63
2.4.27 Second New York StudN - Varcla . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
2.4.28 Hyrbin Study of Adenocarcinoma - Wang . . . . . . . . . . . . . . . . . .. . . . . . 68
2.4.29 Los Angeles Study - W,w . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
2.4.30 North-East China Study - Wu-Wiiliarns . . . . . . . . .. . . . . . . . . . . . . . . . 69
2.4.31 New Jersey Study - Ziegler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
2.5 Case-Control Studies of Bladder Cancer . . . . . . . . . . . . . . . . . . . . . . . . 73
2.5,1 Canadian Study - Burch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
2.5:2 US Study - Kabat 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
2.6 Casc-ControliStudies of Cervix Cancer . . . . . . . . . . . . . . . . . . . . . . . . . 75
2.6.1 Gothenburg Study - Hellberg . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
2.6.2 Utah Study - Slattery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
2:7 Case-Control Studies of Heart' Disease . . . . . . . . . . . . . . . . . . . . . . . . . 77
2.7.1 Chinese Study - He . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
2.7:2 Utah Study- Martin . . . . . . . . . . . . . . . . ., . . ., ., . . . . . . . . ... ..... . 79
2.7.3 US Study- Palmer . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . ., . . . . . 79
2.8 Case-Control Study of Chronic Obstructive Pulmonary Disease . . . . . . . . . . . 801
2.8.1 Greek Study - Kalandidi I . . . . . . . . . . . . ., . . . ., . . . . . . . . . . . . . . . 80
,
2.9 Case{ontrol Study of Stroke ............................... , , 82
2.9.1 Australian Study - Donnan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82

I
I
ii
Contents
3 Lung Cancer
VII
3.1 Seleaion of Studirs for Detailed Consideration .................... $3
3.2 Features of the 29 Studies Included . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
3.2:1 Study Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
83
.
3.2.2 (i.ocation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. 84
3:2.3 Time of Death/Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . . . . $4
3:2.4 The Cases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
84
3.2.5 The Controls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., ., . . . . . . .
88
3.2.6 Sources or Information . . ., ., . . . . . . . . . . . ., . . . ., . . . . . . . . . . . . . .
93
3.2.7 Non-Response . . . . . . . . . . . . . . . . ., . . . . . . . . . . . . . . . . . . . . . 95
3.2.8' indices of ETS Exposure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
3.2.9 Smoking Status of the Subjects . . . . . . . . . . . . i . . . . . . . . . . . . . . . . . 98
3.2.10 Confounding Variablt:s . . . . . ., . . . . . . . . . . . . . . . . . . . . . . . . . . . .
101
3.3 Summary of Results from the 29 Studies . . . . . . . . . . . . . . . . . . . . . . . . 101
3.3.1 Main Index - Spouse Smoking or Nearest Equivalent . . . . . . . . . .. . .. . .. . . 101
3.3.2 Histological: Type of Lung Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . ., . 109
3.3.3 l.eveUof Exposure ., . . . . ... . . . . . . . . . . . . . . . . . . . I1 l,
3.3.4 Variation in Relative Risk According to Other Factors . . . . . . . . . . . . . . . . 113
3.3.5 Other Indices of ETS Exposure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
3.3,6 'Attributable Risk' from ETS Exposure . . . . . . . . . . . . . . . . . . . . . . . . . 119
3.3.7 Comparability of Associations with ETS Exposure and Active Smoking ...... 123
3.4 bnter9reution of the Findings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
3:4.1 The Main Findings . . . . . . . . . . . . . . . . . . . . . . ., . . . . 1,24
3.4.2 Plausibility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
125
3.4.3 Explanations to Be Considered . . . . . . . . . . . . . . . . . . ., . . . . . . . . . . . 127
3.4.4 Misclassification of Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
3.4.5 Misciassifintion of ETS Ezposure . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
3.4.6 Lack of Comparability of Cases and Controls . . . . . . . . . . . . . . . . . . . . . 130
3.4.7 Other Study Weaknesses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
3:4: 8 Confounding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
3.4'.8.1' Age . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. ., 133
3.4.8.2 Marital Status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., ., . . . . .
. 134
3.4.8.3 Other Confounding Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
135
3.4.8.4 Conclusions Regarding Confounding . . . . . . . . . . . . . . . . . . . . . . . . . . 142
3.4.9 Misclassification of Active Smoking Status . . . . . . . . . . . . . . . . . . . . . . . 142
3.4.9.1 The Problem . . . . . . . . . . . . . . ... . . .. . . . . . . . . . . . . . . .. . ., . . .
. 142
3.4.9.2 Major and Minor Sourtxs of Bias . . . . . . . . . . . . . . . . . ., ., . . . . . . . . .
143
3.4.9.3 What I,eve1 of Misclassification Would Be Needed to Enplain~the Observed
Associations of Spouse Smoking with Lung Canoer7' . . . . . . . . . . . . . . . . . 146
3.4.9.4 Evidence on Extent of Misclassification . . . . . . . . . . . . . . . . . . . . . . . ., .,
150
3.4.9.5 Evidence on Extent of Smoking Habit Concordance . . . . . . . . . . .. . .. . . . . 158
3.4.9.6 Conclusions Regarding Misclassi6aation . . . . . . . . . . . . . . . . . . . . . . . . 162
3.4.10 Publintion Bias and Other Issues in Meta-Analysis . . . . . . . . . . . . . . . . . . 164
3.5 Overall Assessment of the Evidence on ETS and Lung Caneer; ........... 166
202351209:114

V1I1 Contents
4 Other Cancers
4.1 Studies Providing Data .................................. . 168
4.2 Results ., . . . . . . . . . . ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
168
4.2.1 Weaknesses of Some Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
4.2.2' Ovcrall Risk . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . . . . . . . . . . . .
169
4.2.3 Lip: Oral Cavity and Pharynz . ., . . . . . . . . . . . . ., . . . . . . . . . . . . . . . 172
4.2.4 Digestive System . . . . . . . . ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
173
4.2.5 Respiratory Sites Other Than the Lung . . . . . . . . . . . . . . . . . . . . . . . . . 174
4.2.6 Bone, Connective Tissue and Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
4.2.7 Breast . . . . . ., . . . . . ., . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . .
. . 175
4.2.8 Female Genital System. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 176
4.2.9 Male Genital System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
4.2.10 Unnary Tract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .~ . . . . . .
II79
4.211 Eyc, Brain and Nervous System . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., 179
4.2.12 Endocrine Glands . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . .
180
4.2.13' Lymphatic and Haematopoictic Tissue . . . . . . . . . . . . . . . . . . . . . . . . . 180
4.2.14: Other Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
181
4.3 Discussion and Conclusions . . . ., . . . ., . . . . . . . . . . . . . . . . . . . . . . . 181
5 Heart Disease
5,1 Studies Providing Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
5.2 Features of the Studies Included . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
186
5.4 Discussion and Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . 193
6 Other Diseases
6.1 Studies Providing Data . . . . . . . . . . ., . . ., . ., . ., . . . . . . . . . . . . . . . .
197'
6.2 Results . . . . . . . . . . . . ., ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
197
6.2.1 Tuberculosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . . . . . . . . .
197
6.2.2 Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . . . . . . .
. 197
6.2.3 Cerebrovascular Disease . . . . . . . . . . . . . . . . . . . . ., . . . . . . . . . . . . 198
6.2.4 Respiratory Diseases . . . . . . . . . . . . . . . . . . . . ., ., . . . . . . . . . . . . .
199
6,2.5 Diseases of the Digestive System . . . . . . . . . ., . . . . . . . . . . . . . . . . . . 200
6.2.6 Gastro-Iotestinal1 Ulcer . . ., ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
200
6.2.7 Cirrbosis of the Liver . . . ., ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
201
6.2.8 Diseases of the Genito-Urinary System . . . . . . . . . . . . . . . . . . . . . . . . . 201
6.2.9 Accidental Causes of Death . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
6.2.10 Suicide . . . . ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. 201.
6.2.11 Ot her Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
201
6.3 Discussion and Conclusions . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202

Contents
7 Overall Risk of Mortality
Ix
7.1 Studies Providing Data .................................. 203
7.2 Results ........................................... , 203
7.3 Discussion and Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . .
201
8 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 208
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210
Subject Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21'8'
h.

-1
)
Heart Disease
5.1 Studies Providing Data
i
Eleven studies have provide& information on the relationship ofl ETS to
risk of cardiovascular disease. Seven of these are prospective studies, 5
eonducted in the USA (Butler, Garland, Humble 11, Sandler 11, Svendsen),
I in Japan (Hirayama) and I in Scotland (Hole). Four are case-control
studies, 2 in the USA (Martin, Palmer), I in China (He) and I in England
(Lee).
Three prospective studies which have reported results for lung cancer
(Garfinkel I), totat cancer (Reynolds) or all-cause mortality (Vanden-
broucke) have not reported results for heart disease. While the numbers of
deaths would not be substantial for the last 2 studies. the fact that the
first, the American Cancer Society million person study has not provided
information is a wastage of resource. This study alone would certainly
have had data on more deaths/cases than all! the i l published studies
combined!
5:2 Eeatures of the Studies Included
It should be noted that very little information is available for 3 of the 1 L
studies considered: the prospective study of Butler, and the case-control
studies of Martin and Palmer for which the only published data consist of
abstracts.
The number of deaths/cases in some studies is verv small. There are 4
studies with extremely small numbers (Svendsen, 13; Garland, 19; Martin,
23; He, 34)4 with quite small numbers (Humble II, 76; Butler, 80; Hole,
84; Lee, l18), and 1' (Paltner, 336 in ever smokers and never smokers
combined) which, though of moderate size, has not presented findings in a
form~to allow proper evaluation. Considering the prevalence of heart dis-

5 Hean Dssease 185
ease among never smokers - very much higher than from lung cancer - it is
surprising that by now there are only 2 published' studies for reporting
results based on reasonably substantial numbers of deaths/cases (Hiraya-
ma, 494; Sandier It 1,358).
Of the 7 prospective studies, 4 involved study subjects attending for
an examination during which blood pressure, cholesterol and body mass
index were measured. It is unfortunate that neither of the 2 substantial
studies collected information on these classical risk factors for heart dis-
ease. The factors used by the authors for adjustment - occupation by
Hirayamaand schooling; housing quality, and marital status by Sandler I1
- are not those which firstoccur as being most relevant in a study of heart
disease.
Some of the studies have problems regarding representativeness of the
subjects. Thus in both the Garland and Hole studies, about 20% of the
population did not attend for examination, with a possibility of bias if
failure to attend was associated both with ETS exposure and risk of death
from heart disease. ln the large Sandier lt study, only deaths in Washing-
ton County were recorded, again imparting a danger of bias if ETS is
associated with the chance of migration out of the county. The Svendsen
study, was based on the well-known Multiple Risk Factor Intervention
Trial, which involved people at very high risk of heart disease base& on
their smoking, blood pressure and cholesterol levels. Since the paper con-
cerned never smokers, all the subjects involwed most probably exhibited
abnormally high blood pressure and'/or cholesterol levels. The Butler study
involved Seventh-Day Adventists, an atypical population with regard to
many variables.
The 2 studies which provided data on by far the largest number of
deaths are both open to criticismas detailed in sections 2.2.2 (Hirayama)
and 2.2.7 (Sandler 1~1), and also in section 4.2:1. It is interesting to note that
both studies have publishe& inconsistent results for women. In 1981,
Hirayama presented results showing no association of heart disease with
husband smoking, based on follow-up of his population to 1979. In 1984,
he reported results which showed a significant association, based on fol,
low-up of his population to 1981. These results implied an implausibly
strong relationship of heart disease to smoking by the husband when
deaths occurring in 1979-81 were considered (a fact pointed out by Lre in
correspondence in the New Zealand MedicalJoarnal [26, 27J). As a result,
Hirayama published revised figures for follow-up to 1979, indicating that
the data published in 1981 were incorrect.

166 Environmental,TobacooSmoke and Morulitj
Helsing et al. [40]I and Sandier et al. [43] have both presented (in
Table 4 of each paper) results for risk of arteriosclerotie heart disease in
relation to ETS exposure. Based' on ddentical numbers of deaths an&stated
adjustment factors, the reported relative risks and confidence limits for
men were identical. Inexplicably, however, this was not the case for wom-
en, where relative risks and' confidence limits both varied. Given the rela-
tively larger contribution of the Hirayama an& Sandler II results to the
overall number of heart disease cases studied4 such~diffcrenccs in reported
findings are rather disconcerting.
53 Results
Table 5.1 summarizes results for exposure to ETS from the spouse or in the
household. Before considering the findings, some points are worth not-
ing:
(i) As far as can be ascertained, alli the relative risks are for never smok-
ers.
(ii) The index was based on smoking by the spouse in 7 studies (Butler,
Garland; He, Hirayama, Humble il, Lee, Svendsen), only married
women being considered, except perhaps in the Chinese study where
single women were included with the wives of non-smoking husbands.
In 2 studies (Tvlartin, Palmer) thc index used is not known. The Hole
study compared people living at the same address as a study partici-
pant who had ever smoked with people who lived arthe same address
as a study participant who had never smokedl with no other studyy
participant at that address ever having smoked. The Sandler 11, , stud.
used a complex index of exposure, but for the results in Table 5.1 it
amounted to a comparison of people living in the household where
some adult had ever smoked with people in a household' where no
adult had' ever smoked.
(iii) When a study has presented different findings at different time points
for apparently the same comparison, the later publication has been
used, namely, Hirayama [23) and not his 198'I paper [2), and Sandier
et al. [43) and not Helsing et al. (40):
(iv) Ifi the authors have presented adjusted relative risks these have nor-
mally been given in Table 5: f. There are some exceptions. First, the
relative risk of 14.9 by Garland et al. [38), adjusted for age, systolic
blood pressuretotal cholesterol, obesity index and years of marriagc,

5 Heart Disease
Table5.1' Heart disca.sc risk in never smokers in relation to spouse/household smoking
187
Study Sex Cases Relative risk
(95 Ya limits) Factors'
adjusted for
U E
Butler F 20 60 1.05 (0;65-1.70): Age
Garland F 2 17 3.51 (0:80-15.3) None'-
He F 9 25 1.50 See text
Hirayama F 118 376 1. fS (0.94-1.42) - Age of wife
Hole
Gillis et a1.
F
2 19
3.56 (0:83-15.4):
None3
M 18 14 1.30 (0:64.2.64) None3
Hole eral. M+F 30 54 2.01,(1.21-3.35) Age. sex.,class. BP:
Huasble lI
F
27' 49
1.59y0.99-2.57) cho11 BbS7
Age, sex. BP. chol.
Ltt
F
22 55
0:97 (0!56-1.69), BMI
None!i
M 26 15 1.34 (0:64-2:80); None'
Martin F -23- 2.6 None=
Palmer F -?- 1.2 (signifinnce Not known
unknown)
Sandier Il F 437 551i 1.19 (1.04-1.36) Age. schooling.
M 248 122 1.31 (1.05-1.64) housing: maritall
Svendsen
M
8 5
2.23 (0.72-6.92) sutus
Age. BP; chol...-t.
drinks. education
U I- Unexposcd; E - exposed.
' BP - blood aressure; chol - eholesterol;, BMU- body, mass index: wt - wcight..
~ See text_
s Adjustment for age had l'tttle effect, and adjusted 95% Iimits could not be calculated.
'Numbers of cases are approximate, based on age-adjusted rates.
has not been usedL It would be incredibly unstable (estimated 95%
limits, about 0.2-5(90)sinee it is probably impossible to adjust prop-
erly for multiple factors with so few deaths. Mantel [pen. commun.]
has also said that 14.9 was an error, the appropriate value being log,
(14.9) or 2:71!
2
in-_ ~'

198 Environmental Tobacco Smoke and Mortality
Secondly, unadjusted relative risks have been used for the individual
sex results from the Hole study (published in Gillis et al [29]), since
age standarditation had very little effect and relative risks could only
be properly calculated for the unadjusted data.
(v) The relative risk given in the He study [102], a case-control study in
which there was matching omagc, race, place of residence and occupa-
tion, is adjusted for previous and family history of hypertension,
family history of coronan heart disease, amount of exercise, history of
drinking, and hypercholesterolaemia. Confidence limits could not be
calculated, but the relative risk was stated to be significanttp < 0:01),
but this seems not to be true (see section 2'.7:1).
(vi) The results presented in Table 5.1 for the H'irayama study are for
ischaemic heart disease. Hirayama [20] notes that no significant rela-
tionship was seen between spouse smoking and risk of 'other heart
disease' (undefined), base& on 68& deaths, or risk of hypertensive
heart disease, based on 226 deaths. Relative risk estimates were not
provided for these two disease categories.
Table 5.I provides 4 independent relative risk estimates for men and
10 for women; 13 of which.are greater than 1, with 4 of them significant:
both the male and female estimates for the Sandltr IC study, and the female
estimates for the He an& Manin studies. Hole also showed a significantl}
increased relative risk when results for the sexes were combined. Although
an overall estimate of relative risk (as for example calculated by Wells [7])
is probably of little meaning given the extreme variability in study designs
and populations involved, the data in this table - considered without
regard to study design and a variety of other methodological problems -
indicate a weak association between exposure to ETS from the spouse or in
the household and' risk of heart disease.
Five of the l l studies provided some information on risk of coronary,
beam disease and extent of exposure to ETS from the spouse or in the
household (Table 5.2): The Hirayama and He studies both showed evi-
dence of a dose-response relationship; with a significant (p < 0.05) trend
and elevation in risk for women whose husbands smoked 20 or more cig-
arettes a day. The Hole and Svendsen studies also showed the highest riskk
in~the highest exposure groupthough here numbers of deaths were smalli
and' the trend statistic was not significant. In the large Sandler 11 study
there was no evidence of a relationship of risk to ETS exposure in either
sex, risk of heart disease being similar in those classified as exposed to light
or heavy ETS exposure.

5 Heart Disease
189
Table 5.2 Heart disea.cc risk in never, smokers in relation to extent of spousehrousehold smoking
Study Sex Exposure
Hirayattu F Husband:
never smoker
ex-smoker or current
1-19 cigs/day
current 20+ eiYs/day
He F Husband:
never smoked' during marriagc
smoked 1-20 cigs/day
smoked 21+ eigs/day
Hole F Household smokmg
none
low,
high (cohabitant 15+ cigslday)
Sandier !1 Household exposure (tcare)`.
F 0(none)
1-5 (light)
6+ (heavy)
M 0(none)
I-S (light)
6+ (heavy)
Svendsen M- Wife::
did not smoke
smoked 1-19 cigs/day
smoked 20+ cigslday
Cases Relative Factors
risk adjusted for
118 1.00 Age of wife
240 1.08
136 1.30-
` Cases and
9 1.00 eontrols
12 230 matched for
13 6.86 age, race,
+ occupation,
cesidena
3 1.00 Age
14 2.09
16 4.12
437 1.00 Age
252 1.20 schooling,
299 1.27 housing
248 1.00 quality,
56 1.39 marital status
66 1.24
8 1.00 0 None
1 0.90
4 3.21
Information on hean disease in relation to other indices of ETS expo-
sure is fairly sparse. In the Lee study, subjects were classified on a score
rangin,g frorn 0 to 12 according to whether they considered they were
exposed not at all (0), a little (1), average (2), or a lot (3-12), separately for
at home, at work, during travel; and during leisure. No significant relation-
ships were seen,,relative risk estimates for scores 0-1, 2-4 and 5-12 being
1, 0.43 and 0.43 in males (based on 30 deaths), and 1, 0.59 and 0.9 1 in
females (based on 36 deaths):
~a~~Sg :1.22
0
G_'! ~! ~'F

190
Table 5.3 Environmental Tobacco Smoke and Mortality
Effect, of adjiestment for various factors on estimated rel'ative risk of heart disease in never
smokers according to spouse/household smoking
Study Sex Adjustment factors Relative risk
(959b limits)
Butler, F None 1.36 (0.82-215)
Age 1.05 (0.65-1.70)
He F Matching factors (age, race, residence,
occupation) onl)
3.52 (11.43-8.65).
Matching factors.,also previous and
family history of hypertension,
familv history of CHD. exercise,
drinking, hypercholesterolacmia
.50
Hirayama F None 1.00 (0!8'1-1!.23)
Age of wife 1.15 (0;94-1'.42)
Age of husband! 1.15 (0;93-1.41)
Age and occupation of husband 1.16 (0.94-1.43)
Holt F None 3.56 (0:83-1 S:4)
Gillis et aL Age 3.25
M None 1.30 (0.64-2.64)
! Age 1.29
Hole et all M+F Age 1.75 (1.1i0-2:83)
Age, sex, social class. BPchol, BMI 2.01 (1.21-135)
Huntblt If F Age 1.34 (0.84-2.21)
Age, BP, ehot! Bh4I 1.59 (0.99-2.57)
Lee F None 0.97 (0.56-1.69)
Age, marital'status 0.93
M None 1.34 (0.64-`2.80)
Age, marital status 1.24.
Sandler 11 F None 0;66 (0:59-0.75)
Age, housing quality,
schooling, marital status
1.19 (1.04-1.36)
M None 1I.17 (0.95-1.46)
Agehousing quality;
schooling, marital status
1.31 (1.05-1.64)
Svendscn M None 2:12 (0.69-6.46),
Age, BP, chol, wt, diinks/week, education 2:23 (0.72-6.92)1
~...',
BMI - Body mass index; BP - blood pressure; ehol- eholesterolrCH'U - eoronary heart
disese; wt - weight.
~~.
l~'
"-

©
5 Heart Disease
®
191'
In the Svendsen study, a relative risk estimate, adjusted for age andd
wife's smoking status, of 2.6 (p - 0.23; 95% limits, 0,5-12.79 was derived
when men whose co-workers smoked: were compared with men whose co+
workers did not. This result, and that in Table 5.1, was for coronary death.
Svendsen also provided results for the end-point fatal or non-fatal coro-
nary event. Here, relative risk estimates were derived for four categories:
(a) neither: wife nor co-worker smoked, f.0 (base); (b) co-Worker smoked
but not wife, 1.U; (c) wife smoked but not co-worker,-11.2: (d),both wife and
co-worker smoked, 1.7.
No result was significant. In the studti by Butler which, in the
AHSMOG eohortrelated heart disease risk to the number of years lived&
and the number of years worked with a smokcr, some 'suggestion' or 'in-
dication' of an effect was reported in both sexes, but no, detailed results
were reported.
No other study provided information on other indices of exposure. In
the study by He, relative risks of I, 1.83, 3.07 and' 5.49 were reported in
relation to 0, I-10,, 1 1-20: and' 21+ years of ETS exposure, and relative
risks, of I', 1.54, 2:305.07 and 12.67 were reported in relation,to 0; 1-199,
200-399, 400-599 and 600+ cigarette-years of smoking by the husband.
Both, trends were statistically signif cant (p < 0.01).
t,eaving aside the Garland study for reasons noted in~ subsection (iv)
above, 7 studies provided some information on the extent to which adjust-
ment for various risk factors affecte6the estimates of heart disease risk in
relation to spouselhousehold smoking. The results are summarized in.
Tablc 5.3.
Two main conclusions can be drawn from this tabl'e. First. that in
some studies age adjustment made a substantial difference to the relative
risk. This effect, which would depend on the design of the study and on the
frequency of smoking by age and sex in the eountn concerned, is evident
in the Hirayama study and is also probably a contributor to the lgrge asso-
ciation reported in the Sandler II study.
The second main conclusion is that there is no clear effect from addi-
tional adjustment- for the classical coronan risk factors. Thus, while the
Hole, Humble 11 - and perhaps the Svendsen - studies showed some
increase in relative risk after adjustment, the He study showed a substan,
tial' decrease.
Some of the prospective studies cast more light on the possibility of
confounding by various risk factors, since they present data comparing
exposed and non-exposed women at the start of the stud'\. The results are
2023,512224

192 Environmental Tobacco Smoke and Morsality.
Table 5.4 Comparison of heart disease risk facton in tTSexposed and non-FLS-exposed subjeets
Study Sex Risk factor Spouselbousehold Signifi«
exposure nnce
no yes
Sandier 1'J F School gradc(1,2+) (%) 33:8 35.4 p < 0.1
Housing index (&-10), (%) 83,3' 81.1 p < 0.01
M School'.grade (12+) (%) 38.0 43.8 p < 0.01
Housing index ($-I0), (96) 83.8~ 80.4 p < 0.05
Garland F Years of marriage Mean 36.01 34.2 p < 0:1
Systolic blood pressure Mean 140.1 138_2 NS
Obesity index Mean 3.50 3.43 NS
Plasma cholesterol Mean 225.7 226.7 NS
Svendsen M Diastolic blood pressurt Mean 103.1 I'.03:3 NS
Systolic blood pressure Mean 150.8 152.3 NS
Serum cholesterol Mean 264.4 266.0 NS
HDL eholesterol! Mean 42:7 43.4 NS
LDL cholesterol Mean 167.1 166,5 NS
Weight (Ibs) Mean 190.4 194.6 p < 0.05
~ Drinkslweek Mean 7.6 9.7 p < 0.01
Education (years) Mean 14.2 13.8 p - 0.05
lncome (S 000), Mean 22.3 22.1 NS
HDL - High d'ensity lipoprotein; LDL - low density lipoprotein.
summarized in Table 5.4. Significant differences were seen in respect of
weight (ETS-exposed heavier), drinks per week (ETS~exposed drink more),
housing index (ETS-exposed~worse);,and years of ed'ucation (ETS-exposed
more in Sandler 11, less in Svendsen), but is not clear that these differences
were large enough to cause substantial bias. The Chinese case-control study
of He also reported differences in blood fat and apolipoprotein levels
according to ETS exposure, but did not, attempt to adjust for these in the
analysis.
One risk factor which might be relevantbut which was not investi-
gated, was the number of cohabitants. In the Sandier 11 and Hole studies
the index of ETS exposure seemed b.+ its very construction to be correlated
with the number of cohabitants. In particular, the Sandler 11: study would
®

5 Heart Disease
1'93
Table 5,5 Effect of other variables on estimated relative risk of hean, disease in never smokers
aaoording to spnuse smoking
Study Sex VariableJlevel Relative nisk'
(95Y% limits) Factors
adjusted for
Hirayana F Age of wife: None
40-49 0.87 (0.47-1.62).
50-59 L03 (0.72-1.46)
60+ 1.30 :(0.9$- L.73)
Age of husband: Nbne
40-49 1,.34' (0,74-2.42)
50-59 1.25 (0.81-1.92)
6U+ 1,07 (0.83-1.40);
Occupation:
agricultural'worker I
1.32 (0.99-1.74) Age of husband
other 0.99 (0:72-1.35)
Humble Il F Blacks 1.78 (0.86-3.71) Age, BP; chol,,
High social status Whites 1.97 (0.72-5.34) BMI
Low social status Whites 0.79 (0.32-1.96)
BMI - Body mass index; BP - blood pressure; chol - cholesterol:
I For wives whose husband smoked cornpared to t,hose whose husband did not smoke.
have included all people living on their own in the non-exposed group, and
both studies were very likely to include people living in homes with many
occupants in the exposed group. Since household size may correlate with
many facets of disease, it seems to be a statistical error not to adjust for it
in analysis.
Two studies provided some information on variation in relative risk
according to the level of some risk factors. Results are summarized in
Table 5.5, and show how the association with ETS exposure varies by'age
and occupation in the Hirayama study and by race and social, status in
the Humble 11 study. Although the association with spouse smoking is
evident only in agricultural workers in the Hirayama study and only in
Blacks and high social status Whites in the Humble 11 study, there is in
fact no significant heterogeneity between the relative risk estimates in
either study.
~a2;~~1~126

194 Environmental Tobaeao Smoke and Morulily
5.4 Discussion and Conciusions.
Although lung cancer is a rare cause of death in those who have never
smoked, heart disease is not, and it is much easier, to conduct an ade-'
quately large study for heart disease than for lung cancer. Yet there are far
more studies of ETS and lung cancer than of ETS and heart disease. Ut is
striking that so many of the latter studies are based on very smallinumbers
of deaths or cases and/or have not been properly reported in the litera-
ture.
Only 2 studies are sufficiently large to pick up a moderate increase in
risk as statistically significantand neither is satisfactory: Both lack data on
classical heart: disease risk factors, such as blood pressurecholtsterol and
body mass index, and both have a number of problems that have been
referred to in detail earlier. Certainly, neither is a straightforward prospec-
tive study conducted acevrding to acceptable methodology, with collection
of risk factor data at intervals and essentially complete follow-up of
deaths.
Apart from the generdlly unimpressive nature of the studies that have
been oonducted, the other circumstance that stands out is that 13 of the 14
sex-specific estimates of relative risk of heart disease for spouse or house-
hold exposure imTable 5.1 show a positive (though for the most part not
statistically significant) association. !n considering this fact, a number of
points have to be taken into account:
(i) Active smokers have an increased risk of heart disease, as is clear from
numerous epidemiologicalistud'ies. However, the relative risk is much
lower than it is for lung cancer. For example, the 1989 US Surgeon
General's report [711j cites results from the latest American Cancer
Society prospective study showing that, compared with, never smok-
ers, current smokers have relative risks of heart disease of 1.94 in
malesand 1.78 in femalesas compared to relative risks of lung cancer
of 22.36 in males and 11'.94 in females.
Vapour phase components of cigarette smoke have been implicated in
the aetiology of heart disease (rather than particulate phase compo-
nents for lung cancer (1j), and the relative exposure of ETS-cxposed
non-smokers as compared with active smokers is substantially higher
for vapour phase than for particulate phase components, but the low
relative risks for heart disease for active smoking suongly suggest that
if ETS does increase risk of heart disease this increase would be quite
modest. The six estimates of over 1.5 in Table 5.1 seem difficult to

5 Hurt Disease 1955
rtooncile with the dosimetry, especially bearing in mind that active
smokers have very substantialiETS exposure.
(ii) Heart disease is certainly multifactorial, and many of the risk factors
have not been taken into account in many of the studies. Confounding
is therefore a possibility, particularly in the 2 studies (Hole,, Sandler,
Il), where the index of ETS exposure used was likely to be extremely,
strongly correlated with household size. Whilt the evidence discussed'
in Tables 5.3 and 5,4 does not clearly derttonstr;Lte important con-
founding by blood pressurecholesterol or body mass index it is rather
limited and somewhat inconsistent. More evidence is clearly needed
on this important potential source of bias.
(iii) Bias due to misclassilication of active smokiiig status is likely to occur,
but since the increase in risk in relation to active smoking is relatively
so much less for heart disease than for lung cancer, the extent of the
bias will be that much smaller. Since the bias is proportional to the
excess risk (see section 3.4.9), its magnitude will be only 5-1096 of that
illustrated in typical situations for lung cancer.
(iv) Publication bias is one major source of bias that can certainly not be
excluded as relevant. There are two major reasons for believing this
may be an important issue. First, there is a strong tendenc) in
Table 5.1 for the large relative risk estimates to be based on very small,
studies. From, the 13 sex-specific estimates, the rank correlation is
highly significantly (p < 0.05) negative. Who would bother to try to
publish a paper showing no association based on very few deaths?
Sec,ondly,,certain studies that couldipublish findings have not done so.
Of particular importance is the fact that the first American Cancer Society
study of over a million men and' women, which published results for ETS
and lung cancer in 1981, has never published results for ETS and heart
disease. 11 is very likely that no association was found. If this were so; it
would have a very large effect on the results of any meta-analysis (or con-
sequent estimate of heart disease deaths 'due to ETS').
Mainly because of the problems caused by the strong likelihood' of
severe publication bias, it cannot be concluded from the existing evidence
that ETS is associated with heart disease. The present author understands
that the American Cancer Society intends to publish within the next year ~
or so findings related to ETS based on its second large prospective study: lt ~
is hoped that results from its first prospective study will also be released. r~
Until there is such evidence, and hopefully also evidence from other stud- W
ies involving substantial numbers of deaths from heart disease with good ~
~
~
~
~

I
196 Environtnental Tobacco Smoke and Mortality
control of confounding and with evidence on ETS exposure from sources
other than the spouse or in the home, it is certainly premature to comc to
any conclusions.
Note Added in Proof
Since this section was completed. Dobson et al. (166J, reported results from an Australian
easecontrol' study of myocardial infarction and suddcn death.,Among non-smokers there
was no positive relationship of risk to ETS exposure at work in either sex. Nor was therc a
positive relationship of ETS exposure at home in males. In contrast, in femalbs a signifi-
nnt positive relationship of risk was rtported to ETS exposure at home. In this study,
data on smoking habits were collected by completely difierent methods for ea.ses and
oontroas, the potential of bias being underlined by the wide variation in smoking fre-
Quenay reported in controls according to how and where the data were collected. In
addition, virtually no relevant confounding variables were taken into aeeount,.
